US 12,111,320 B2
1,1′-[(substituted alkyl)imino]bis(alkylene)]bis-ferrocenes and their use in electrochemical assays by labelling substrates of interest
Barrie Marsh, Trowbridge (GB); Christopher Frost, Bath And Northeast Somerset (GB); and David Pearce, Trowbridge (GB)
Assigned to Binx Health Limited, Trowbridge (GB)
Filed by Binx Health Limited, Trowbridge (GB)
Filed on Oct. 12, 2023, as Appl. No. 18/485,575.
Application 17/099,290 is a division of application No. 16/664,306, filed on Oct. 25, 2019, granted, now 10,837,967, issued on Nov. 17, 2020.
Application 18/485,575 is a continuation of application No. 17/099,290, filed on Nov. 16, 2020, granted, now 11,808,768.
Application 16/664,306 is a continuation of application No. 15/906,241, filed on Feb. 27, 2018, granted, now 10,502,744, issued on Dec. 10, 2019.
Application 15/906,241 is a continuation of application No. 14/410,296, abandoned, previously published as PCT/GB2013/051643, filed on Jun. 21, 2013.
Claims priority of application No. 1211157 (GB), filed on Jun. 22, 2012.
Prior Publication US 2024/0060984 A1, Feb. 22, 2024
This patent is subject to a terminal disclaimer.
Int. Cl. G01N 33/58 (2006.01); C07F 17/02 (2006.01); C12Q 1/6816 (2018.01)
CPC G01N 33/58 (2013.01) [C07F 17/02 (2013.01); C12Q 1/6816 (2013.01)] 17 Claims
 
1. A compound selected from the group consisting of:
6-(bis((1′-iodoferrocenyl)1-methylferrocenyl)amino)hexan-1-ol;
6-(bis((1′-(4-nitrophenyl)ferronceyl)1-methylferrocenyl)amino) hexan-1-ol;
6-(bis((1′-(1-furanyl)ferrocenyl)1-methylferrocenyl)amino)hexan-1-ol; and
6-(bis((2-cyano)1-methylferrocenyl)amino)hexan-1-ol.